BALDWIN WEALTH PARTNERS LLC/MA LGND — LIGAND PHARMACEUTICALS INC

Ownership history in BALDWIN WEALTH PARTNERS LLC/MA  ·  3 quarters on record

AI Ownership Summary

BALDWIN WEALTH PARTNERS LLC/MA reported LIGAND PHARMACEUTICALS INC (LGND) in 3 quarterly 13F filings from 2024 Q3 through 2026 Q3. Peak portfolio weight reached 0.02% in 2024 Q3. The latest visible filing shows LGND at 0.02% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this LGND ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was BALDWIN WEALTH PARTNERS LLC/MA's position in LIGAND PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

LGND was reported at 0.02% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.02% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

LGND stock page BALDWIN WEALTH PARTNERS LLC/MA fund profile BALDWIN WEALTH PARTNERS LLC/MA full holdings
How BALDWIN WEALTH PARTNERS LLC/MA held LGND — position size vs. price
% of Fund (quarterly)    LGND price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 3 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 REDUCED — — — 893 -18 -2.0% 0.02% $279K 2026-10-13 $303.53
2026 Q2 REDUCED 74.7% -0.6% ✅ 911 -2,684 -74.7% 0.02% $288K 2026-07-14 $300.97
2024 Q3 INITIATED — — — 3,595 — — 0.02% $360K 2024-10-16 $107.16

🏢 Other funds also holding LGND

As of 2026 Q3 — sorted by position size

Chicago Capital, LLC 3Y 7Y 3.99% CONGRESS ASSET MANAGEMENT CO 3Y 7Y 1.33% TEALWOOD ASSET MANAGEMENT INC 3Y 7Y 0.71% CWC Advisors, LLC. 3Y 7Y 0.48% WOODSTOCK CORP 3Y 7Y 0.46% MOODY NATIONAL BANK TRUST DIVISION 3Y 7Y 0.36% Stronghold Wealth Management L.L.C. 0.33% CONTRAVISORY INVESTMENT MANAGEMENT, INC. 3Y 7Y 0.12% GK Wealth Management LLC 0.07% EQUITABLE TRUST CO 3Y 7Y 0.06%

FAQ About BALDWIN WEALTH PARTNERS LLC/MA and LGND

These are the practical questions this page is built to answer before you even open the full history table.

How long has BALDWIN WEALTH PARTNERS LLC/MA reported owning LGND?

BALDWIN WEALTH PARTNERS LLC/MA reported LGND across 3 quarterly 13F filings, from 2024 Q3 through 2026 Q3.

What was the largest reported LGND position in BALDWIN WEALTH PARTNERS LLC/MA's portfolio?

The largest reported portfolio weight for LGND was 0.02% in 2024 Q3.

What is the latest reported LGND position on this page?

The most recent filing on this page is 2026 Q3, when BALDWIN WEALTH PARTNERS LLC/MA reported 893 shares, equal to 0.02% of portfolio, with an estimated market value of $279K.

What does the chart on this LGND ownership page compare?

The chart compares BALDWIN WEALTH PARTNERS LLC/MA's quarterly LGND portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to BALDWIN WEALTH PARTNERS LLC/MA Holdings